Evidence map›Paper›PMID 38586555›Full record

ArticleAnnals of surgical treatment and research2024

Comparison of totally laparoscopic and laparoscopic-assisted approach in gastrectomy with D2 lymphadenectomy for advanced gastric cancer after neoadjuvant chemotherapy: a retrospective comparative study.

Zhenyu Chen, Guangyu Chen, Yan Li, Sha Kou, Tao Wang, Lin Zhang, Yongkuan Cao, Liye Liu

Abstract read
In one paragraph

Article in Annals of surgical treatment and research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhenyu ChenGeneral Surgery Center, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0000-0002-8246-1630
Guangyu ChenGeneral Surgery Center, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0000-0002-8355-6113
Yan LiGeneral Surgery Center, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0009-0008-6787-5588
Sha KouGeneral Surgery Center, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0009-0007-9083-5309
Tao WangGeneral Surgery Center, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0000-0002-7870-3385
Lin ZhangGeneral Surgery Center, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0009-0001-7439-7018
Yongkuan CaoGeneral Surgery Center, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0000-0003-1022-3091
Liye LiuGeneral Surgery Center, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0000-0001-7852-4531

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Neoadjuvant chemotherapy is strongly recommended for advanced gastric cancer due to good local control and a high rate of R0 dissection with this strategy. Minimally invasive techniques such as laparoscopy-assisted or total laparoscopic approaches is becoming more and more acceptable in the treatment for gastric cancer. However, the safety and efficiency of total laparoscopic D2 gastrectomy (TLG) for advanced gastric cancer after neoadjuvant chemotherapy have not been well evaluated. Methods: A retrospective study in a single center from 2014 to 2016 was conducted. A total of 65 locally advanced gastric cancers were treated by laparoscopy-assisted gastrectomy (LAG) or TLG. Parameters which include operation time, blood loss, complications, hospital stay, 3-year overall survival, and 3-year disease-free survival were used for comparison. Results: The time of operation in the TLG group was shorter than in the LAG group (P = 0.013), blood loss was less (P = 0.002) and time to first flatus was shorter (P = 0.039) in the TLG group than that in the LLG group. Intraoperative and postoperative complications were comparable in both groups. No significant difference was found in 3-year overall and disease-free survival. Conclusion: For patients with locally advanced gastric cancer after neoadjuvant chemotherapy, laparoscopic D2 gastrectomy can be considered as a safe and efficient alternative. A further multicenter prospective randomized controlled study is needed to elucidate the applicability of this technique for advanced gastric cancer.

Indexed as

LaparoscopyLymph node excisionNeoadjuvant therapyStomach neoplasms

Identifiers

PMID38586555
PMCPMC10995841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.